世界のNT3成長因子受容体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global NT 3 Growth Factor Receptor Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5898 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、NT3成長因子受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（AZD-7451、ラロトレクチニブ、DS-6051、LM-22B10、その他）、用途別市場規模（乳がん、脳がん、固形がん、結腸がん、線維肉腫、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・NT3成長因子受容体の市場動向 ・企業の競争状況、市場シェア ・NT3成長因子受容体の種類別市場規模と予測2016-2027（AZD-7451、ラロトレクチニブ、DS-6051、LM-22B10、その他） ・NT3成長因子受容体の用途別市場規模と予測2016-2027（乳がん、脳がん、固形がん、結腸がん、線維肉腫、その他） ・NT3成長因子受容体の北米市場規模2016-2027（アメリカ、カナダ） ・NT3成長因子受容体の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・NT3成長因子受容体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・NT3成長因子受容体の中南米市場規模2016-2027（メキシコ、ブラジル） ・NT3成長因子受容体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Array BioPharma Inc、AstraZeneca Plc、Daiichi Sankyo Company Ltd、Handok Inc、Ignyta Inc、Loxo Oncology Inc、Netris Pharma SAS、Plexxikon Inc） ・結論

Market Analysis and Insights: Global NT 3 Growth Factor Receptor Market
The global NT 3 Growth Factor Receptor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NT 3 Growth Factor Receptor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NT 3 Growth Factor Receptor market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NT 3 Growth Factor Receptor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NT 3 Growth Factor Receptor market.

Global NT 3 Growth Factor Receptor Scope and Market Size
NT 3 Growth Factor Receptor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global NT 3 Growth Factor Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
AZD-7451
Larotrectinib
DS-6051
LM-22B10
Others

Segment by Application
Breast Cancer
Brain Cancer
Solid Tumor
Colon Cancer
Fibrosarcoma
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Array BioPharma Inc
AstraZeneca Plc
Daiichi Sankyo Company Ltd
Handok Inc
Ignyta Inc
Loxo Oncology Inc
Netris Pharma SAS
Plexxikon Inc

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NT 3 Growth Factor Receptor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 AZD-7451
1.2.3 Larotrectinib
1.2.4 DS-6051
1.2.5 LM-22B10
1.2.6 Others
1.3 Market by Application
1.3.1 Global NT 3 Growth Factor Receptor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Brain Cancer
1.3.4 Solid Tumor
1.3.5 Colon Cancer
1.3.6 Fibrosarcoma
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global NT 3 Growth Factor Receptor Market Perspective (2016-2027)
2.2 NT 3 Growth Factor Receptor Growth Trends by Regions
2.2.1 NT 3 Growth Factor Receptor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 NT 3 Growth Factor Receptor Historic Market Share by Regions (2016-2021)
2.2.3 NT 3 Growth Factor Receptor Forecasted Market Size by Regions (2022-2027)
2.3 NT 3 Growth Factor Receptor Industry Dynamic
2.3.1 NT 3 Growth Factor Receptor Market Trends
2.3.2 NT 3 Growth Factor Receptor Market Drivers
2.3.3 NT 3 Growth Factor Receptor Market Challenges
2.3.4 NT 3 Growth Factor Receptor Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top NT 3 Growth Factor Receptor Players by Revenue
3.1.1 Global Top NT 3 Growth Factor Receptor Players by Revenue (2016-2021)
3.1.2 Global NT 3 Growth Factor Receptor Revenue Market Share by Players (2016-2021)
3.2 Global NT 3 Growth Factor Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by NT 3 Growth Factor Receptor Revenue
3.4 Global NT 3 Growth Factor Receptor Market Concentration Ratio
3.4.1 Global NT 3 Growth Factor Receptor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NT 3 Growth Factor Receptor Revenue in 2020
3.5 NT 3 Growth Factor Receptor Key Players Head office and Area Served
3.6 Key Players NT 3 Growth Factor Receptor Product Solution and Service
3.7 Date of Enter into NT 3 Growth Factor Receptor Market
3.8 Mergers & Acquisitions, Expansion Plans

4 NT 3 Growth Factor Receptor Breakdown Data by Type
4.1 Global NT 3 Growth Factor Receptor Historic Market Size by Type (2016-2021)
4.2 Global NT 3 Growth Factor Receptor Forecasted Market Size by Type (2022-2027)

5 NT 3 Growth Factor Receptor Breakdown Data by Application
5.1 Global NT 3 Growth Factor Receptor Historic Market Size by Application (2016-2021)
5.2 Global NT 3 Growth Factor Receptor Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America NT 3 Growth Factor Receptor Market Size (2016-2027)
6.2 North America NT 3 Growth Factor Receptor Market Size by Type
6.2.1 North America NT 3 Growth Factor Receptor Market Size by Type (2016-2021)
6.2.2 North America NT 3 Growth Factor Receptor Market Size by Type (2022-2027)
6.2.3 North America NT 3 Growth Factor Receptor Market Size by Type (2016-2027)
6.3 North America NT 3 Growth Factor Receptor Market Size by Application
6.3.1 North America NT 3 Growth Factor Receptor Market Size by Application (2016-2021)
6.3.2 North America NT 3 Growth Factor Receptor Market Size by Application (2022-2027)
6.3.3 North America NT 3 Growth Factor Receptor Market Size by Application (2016-2027)
6.4 North America NT 3 Growth Factor Receptor Market Size by Country
6.4.1 North America NT 3 Growth Factor Receptor Market Size by Country (2016-2021)
6.4.2 North America NT 3 Growth Factor Receptor Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe NT 3 Growth Factor Receptor Market Size (2016-2027)
7.2 Europe NT 3 Growth Factor Receptor Market Size by Type
7.2.1 Europe NT 3 Growth Factor Receptor Market Size by Type (2016-2021)
7.2.2 Europe NT 3 Growth Factor Receptor Market Size by Type (2022-2027)
7.2.3 Europe NT 3 Growth Factor Receptor Market Size by Type (2016-2027)
7.3 Europe NT 3 Growth Factor Receptor Market Size by Application
7.3.1 Europe NT 3 Growth Factor Receptor Market Size by Application (2016-2021)
7.3.2 Europe NT 3 Growth Factor Receptor Market Size by Application (2022-2027)
7.3.3 Europe NT 3 Growth Factor Receptor Market Size by Application (2016-2027)
7.4 Europe NT 3 Growth Factor Receptor Market Size by Country
7.4.1 Europe NT 3 Growth Factor Receptor Market Size by Country (2016-2021)
7.4.2 Europe NT 3 Growth Factor Receptor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific NT 3 Growth Factor Receptor Market Size (2016-2027)
8.2 Asia-Pacific NT 3 Growth Factor Receptor Market Size by Type
8.2.1 Asia-Pacific NT 3 Growth Factor Receptor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific NT 3 Growth Factor Receptor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific NT 3 Growth Factor Receptor Market Size by Type (2016-2027)
8.3 Asia-Pacific NT 3 Growth Factor Receptor Market Size by Application
8.3.1 Asia-Pacific NT 3 Growth Factor Receptor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific NT 3 Growth Factor Receptor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific NT 3 Growth Factor Receptor Market Size by Application (2016-2027)
8.4 Asia-Pacific NT 3 Growth Factor Receptor Market Size by Region
8.4.1 Asia-Pacific NT 3 Growth Factor Receptor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific NT 3 Growth Factor Receptor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America NT 3 Growth Factor Receptor Market Size (2016-2027)
9.2 Latin America NT 3 Growth Factor Receptor Market Size by Type
9.2.1 Latin America NT 3 Growth Factor Receptor Market Size by Type (2016-2021)
9.2.2 Latin America NT 3 Growth Factor Receptor Market Size by Type (2022-2027)
9.2.3 Latin America NT 3 Growth Factor Receptor Market Size by Type (2016-2027)
9.3 Latin America NT 3 Growth Factor Receptor Market Size by Application
9.3.1 Latin America NT 3 Growth Factor Receptor Market Size by Application (2016-2021)
9.3.2 Latin America NT 3 Growth Factor Receptor Market Size by Application (2022-2027)
9.3.3 Latin America NT 3 Growth Factor Receptor Market Size by Application (2016-2027)
9.4 Latin America NT 3 Growth Factor Receptor Market Size by Country
9.4.1 Latin America NT 3 Growth Factor Receptor Market Size by Country (2016-2021)
9.4.2 Latin America NT 3 Growth Factor Receptor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa NT 3 Growth Factor Receptor Market Size (2016-2027)
10.2 Middle East & Africa NT 3 Growth Factor Receptor Market Size by Type
10.2.1 Middle East & Africa NT 3 Growth Factor Receptor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa NT 3 Growth Factor Receptor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa NT 3 Growth Factor Receptor Market Size by Type (2016-2027)
10.3 Middle East & Africa NT 3 Growth Factor Receptor Market Size by Application
10.3.1 Middle East & Africa NT 3 Growth Factor Receptor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa NT 3 Growth Factor Receptor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa NT 3 Growth Factor Receptor Market Size by Application (2016-2027)
10.4 Middle East & Africa NT 3 Growth Factor Receptor Market Size by Country
10.4.1 Middle East & Africa NT 3 Growth Factor Receptor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa NT 3 Growth Factor Receptor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Array BioPharma Inc
11.1.1 Array BioPharma Inc Company Details
11.1.2 Array BioPharma Inc Business Overview
11.1.3 Array BioPharma Inc NT 3 Growth Factor Receptor Introduction
11.1.4 Array BioPharma Inc Revenue in NT 3 Growth Factor Receptor Business (2016-2021)
11.1.5 Array BioPharma Inc Recent Development
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Details
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc NT 3 Growth Factor Receptor Introduction
11.2.4 AstraZeneca Plc Revenue in NT 3 Growth Factor Receptor Business (2016-2021)
11.2.5 AstraZeneca Plc Recent Development
11.3 Daiichi Sankyo Company Ltd
11.3.1 Daiichi Sankyo Company Ltd Company Details
11.3.2 Daiichi Sankyo Company Ltd Business Overview
11.3.3 Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Introduction
11.3.4 Daiichi Sankyo Company Ltd Revenue in NT 3 Growth Factor Receptor Business (2016-2021)
11.3.5 Daiichi Sankyo Company Ltd Recent Development
11.4 Handok Inc
11.4.1 Handok Inc Company Details
11.4.2 Handok Inc Business Overview
11.4.3 Handok Inc NT 3 Growth Factor Receptor Introduction
11.4.4 Handok Inc Revenue in NT 3 Growth Factor Receptor Business (2016-2021)
11.4.5 Handok Inc Recent Development
11.5 Ignyta Inc
11.5.1 Ignyta Inc Company Details
11.5.2 Ignyta Inc Business Overview
11.5.3 Ignyta Inc NT 3 Growth Factor Receptor Introduction
11.5.4 Ignyta Inc Revenue in NT 3 Growth Factor Receptor Business (2016-2021)
11.5.5 Ignyta Inc Recent Development
11.6 Loxo Oncology Inc
11.6.1 Loxo Oncology Inc Company Details
11.6.2 Loxo Oncology Inc Business Overview
11.6.3 Loxo Oncology Inc NT 3 Growth Factor Receptor Introduction
11.6.4 Loxo Oncology Inc Revenue in NT 3 Growth Factor Receptor Business (2016-2021)
11.6.5 Loxo Oncology Inc Recent Development
11.7 Netris Pharma SAS
11.7.1 Netris Pharma SAS Company Details
11.7.2 Netris Pharma SAS Business Overview
11.7.3 Netris Pharma SAS NT 3 Growth Factor Receptor Introduction
11.7.4 Netris Pharma SAS Revenue in NT 3 Growth Factor Receptor Business (2016-2021)
11.7.5 Netris Pharma SAS Recent Development
11.8 Plexxikon Inc
11.8.1 Plexxikon Inc Company Details
11.8.2 Plexxikon Inc Business Overview
11.8.3 Plexxikon Inc NT 3 Growth Factor Receptor Introduction
11.8.4 Plexxikon Inc Revenue in NT 3 Growth Factor Receptor Business (2016-2021)
11.8.5 Plexxikon Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global NT 3 Growth Factor Receptor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of AZD-7451
Table 3. Key Players of Larotrectinib
Table 4. Key Players of DS-6051
Table 5. Key Players of LM-22B10
Table 6. Key Players of Others
Table 7. Global NT 3 Growth Factor Receptor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global NT 3 Growth Factor Receptor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global NT 3 Growth Factor Receptor Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global NT 3 Growth Factor Receptor Market Share by Regions (2016-2021)
Table 11. Global NT 3 Growth Factor Receptor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global NT 3 Growth Factor Receptor Market Share by Regions (2022-2027)
Table 13. NT 3 Growth Factor Receptor Market Trends
Table 14. NT 3 Growth Factor Receptor Market Drivers
Table 15. NT 3 Growth Factor Receptor Market Challenges
Table 16. NT 3 Growth Factor Receptor Market Restraints
Table 17. Global NT 3 Growth Factor Receptor Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global NT 3 Growth Factor Receptor Market Share by Players (2016-2021)
Table 19. Global Top NT 3 Growth Factor Receptor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NT 3 Growth Factor Receptor as of 2020)
Table 20. Ranking of Global Top NT 3 Growth Factor Receptor Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by NT 3 Growth Factor Receptor Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players NT 3 Growth Factor Receptor Product Solution and Service
Table 24. Date of Enter into NT 3 Growth Factor Receptor Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global NT 3 Growth Factor Receptor Market Size by Type (2016-2021) (US$ Million)
Table 27. Global NT 3 Growth Factor Receptor Revenue Market Share by Type (2016-2021)
Table 28. Global NT 3 Growth Factor Receptor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global NT 3 Growth Factor Receptor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global NT 3 Growth Factor Receptor Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global NT 3 Growth Factor Receptor Revenue Market Share by Application (2016-2021)
Table 32. Global NT 3 Growth Factor Receptor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global NT 3 Growth Factor Receptor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America NT 3 Growth Factor Receptor Market Size by Type (2016-2021) (US$ Million)
Table 35. North America NT 3 Growth Factor Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America NT 3 Growth Factor Receptor Market Size by Application (2016-2021) (US$ Million)
Table 37. North America NT 3 Growth Factor Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America NT 3 Growth Factor Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America NT 3 Growth Factor Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe NT 3 Growth Factor Receptor Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe NT 3 Growth Factor Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe NT 3 Growth Factor Receptor Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe NT 3 Growth Factor Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe NT 3 Growth Factor Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe NT 3 Growth Factor Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific NT 3 Growth Factor Receptor Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific NT 3 Growth Factor Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific NT 3 Growth Factor Receptor Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific NT 3 Growth Factor Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific NT 3 Growth Factor Receptor Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific NT 3 Growth Factor Receptor Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America NT 3 Growth Factor Receptor Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America NT 3 Growth Factor Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America NT 3 Growth Factor Receptor Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America NT 3 Growth Factor Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America NT 3 Growth Factor Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America NT 3 Growth Factor Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa NT 3 Growth Factor Receptor Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa NT 3 Growth Factor Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa NT 3 Growth Factor Receptor Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa NT 3 Growth Factor Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa NT 3 Growth Factor Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa NT 3 Growth Factor Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 64. Array BioPharma Inc Company Details
Table 65. Array BioPharma Inc Business Overview
Table 66. Array BioPharma Inc NT 3 Growth Factor Receptor Product
Table 67. Array BioPharma Inc Revenue in NT 3 Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 68. Array BioPharma Inc Recent Development
Table 69. AstraZeneca Plc Company Details
Table 70. AstraZeneca Plc Business Overview
Table 71. AstraZeneca Plc NT 3 Growth Factor Receptor Product
Table 72. AstraZeneca Plc Revenue in NT 3 Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 73. AstraZeneca Plc Recent Development
Table 74. Daiichi Sankyo Company Ltd Company Details
Table 75. Daiichi Sankyo Company Ltd Business Overview
Table 76. Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Product
Table 77. Daiichi Sankyo Company Ltd Revenue in NT 3 Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 78. Daiichi Sankyo Company Ltd Recent Development
Table 79. Handok Inc Company Details
Table 80. Handok Inc Business Overview
Table 81. Handok Inc NT 3 Growth Factor Receptor Product
Table 82. Handok Inc Revenue in NT 3 Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 83. Handok Inc Recent Development
Table 84. Ignyta Inc Company Details
Table 85. Ignyta Inc Business Overview
Table 86. Ignyta Inc NT 3 Growth Factor Receptor Product
Table 87. Ignyta Inc Revenue in NT 3 Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 88. Ignyta Inc Recent Development
Table 89. Loxo Oncology Inc Company Details
Table 90. Loxo Oncology Inc Business Overview
Table 91. Loxo Oncology Inc NT 3 Growth Factor Receptor Product
Table 92. Loxo Oncology Inc Revenue in NT 3 Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 93. Loxo Oncology Inc Recent Development
Table 94. Netris Pharma SAS Company Details
Table 95. Netris Pharma SAS Business Overview
Table 96. Netris Pharma SAS NT 3 Growth Factor Receptor Product
Table 97. Netris Pharma SAS Revenue in NT 3 Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 98. Netris Pharma SAS Recent Development
Table 99. Plexxikon Inc Company Details
Table 100. Plexxikon Inc Business Overview
Table 101. Plexxikon Inc Revenue in NT 3 Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 102. Plexxikon Inc Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NT 3 Growth Factor Receptor Market Share by Type: 2020 VS 2027
Figure 2. AZD-7451 Features
Figure 3. Larotrectinib Features
Figure 4. DS-6051 Features
Figure 5. LM-22B10 Features
Figure 6. Others Features
Figure 7. Global NT 3 Growth Factor Receptor Market Share by Application: 2020 VS 2027
Figure 8. Breast Cancer Case Studies
Figure 9. Brain Cancer Case Studies
Figure 10. Solid Tumor Case Studies
Figure 11. Colon Cancer Case Studies
Figure 12. Fibrosarcoma Case Studies
Figure 13. Others Case Studies
Figure 14. NT 3 Growth Factor Receptor Report Years Considered
Figure 15. Global NT 3 Growth Factor Receptor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global NT 3 Growth Factor Receptor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global NT 3 Growth Factor Receptor Market Share by Regions: 2020 VS 2027
Figure 18. Global NT 3 Growth Factor Receptor Market Share by Regions (2022-2027)
Figure 19. Global NT 3 Growth Factor Receptor Market Share by Players in 2020
Figure 20. Global Top NT 3 Growth Factor Receptor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NT 3 Growth Factor Receptor as of 2020
Figure 21. The Top 10 and 5 Players Market Share by NT 3 Growth Factor Receptor Revenue in 2020
Figure 22. Global NT 3 Growth Factor Receptor Revenue Market Share by Type (2016-2021)
Figure 23. Global NT 3 Growth Factor Receptor Revenue Market Share by Type (2022-2027)
Figure 24. North America NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America NT 3 Growth Factor Receptor Market Share by Type (2016-2027)
Figure 26. North America NT 3 Growth Factor Receptor Market Share by Application (2016-2027)
Figure 27. North America NT 3 Growth Factor Receptor Market Share by Country (2016-2027)
Figure 28. United States NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe NT 3 Growth Factor Receptor Market Share by Type (2016-2027)
Figure 32. Europe NT 3 Growth Factor Receptor Market Share by Application (2016-2027)
Figure 33. Europe NT 3 Growth Factor Receptor Market Share by Country (2016-2027)
Figure 34. Germany NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific NT 3 Growth Factor Receptor Market Share by Type (2016-2027)
Figure 42. Asia-Pacific NT 3 Growth Factor Receptor Market Share by Application (2016-2027)
Figure 43. Asia-Pacific NT 3 Growth Factor Receptor Market Share by Region (2016-2027)
Figure 44. China NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America NT 3 Growth Factor Receptor Market Share by Type (2016-2027)
Figure 52. Latin America NT 3 Growth Factor Receptor Market Share by Application (2016-2027)
Figure 53. Latin America NT 3 Growth Factor Receptor Market Share by Country (2016-2027)
Figure 54. Mexico NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa NT 3 Growth Factor Receptor Market Share by Type (2016-2027)
Figure 58. Middle East & Africa NT 3 Growth Factor Receptor Market Share by Application (2016-2027)
Figure 59. Middle East & Africa NT 3 Growth Factor Receptor Market Share by Country (2016-2027)
Figure 60. Turkey NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE NT 3 Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Array BioPharma Inc Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2016-2021)
Figure 64. AstraZeneca Plc Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2016-2021)
Figure 65. Daiichi Sankyo Company Ltd Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2016-2021)
Figure 66. Handok Inc Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2016-2021)
Figure 67. Ignyta Inc Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2016-2021)
Figure 68. Loxo Oncology Inc Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2016-2021)
Figure 69. Netris Pharma SAS Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2016-2021)
Figure 70. Plexxikon Inc Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---